Variant report
Variant | esv3367090 |
---|---|
Chromosome Location | chr11:102419936-102420198 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28644502 | chr11:102419941-102419942 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs71462701 | chr11:102419943-102419944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71462702 | chr11:102419945-102419946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200697128 | chr11:102419952-102419953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11605359 | chr11:102419953-102419954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs55716564 | chr11:102419961-102419962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562923685 | chr11:102419963-102419964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531898007 | chr11:102419970-102419971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548622880 | chr11:102419971-102419972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12282337 | chr11:102419974-102419975 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs568690014 | chr11:102419976-102419977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531080286 | chr11:102419982-102419983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12282349 | chr11:102420028-102420029 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs547404692 | chr11:102420036-102420037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 17363583 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:102415400-102420200 | Enhancers | GM12878-XiMat | blood |
2 | chr11:102416400-102429400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr11:102416600-102422000 | Weak transcription | Placenta Amnion | Placenta Amnion |
4 | chr11:102416800-102434400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr11:102417400-102420800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr11:102417400-102422800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr11:102417800-102423600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr11:102418200-102423000 | Weak transcription | HSMM | muscle |
9 | chr11:102418200-102423000 | Weak transcription | Osteobl | bone |
10 | chr11:102418200-102423800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr11:102418800-102421400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr11:102419600-102421800 | Weak transcription | Primary B cells from peripheral blood | blood |
13 | chr11:102419600-102422000 | Weak transcription | Gastric | stomach |
14 | chr11:102419600-102429200 | Weak transcription | Lung | lung |